Prolacta Bioscience publishes new research showing reversible engraftment using a synbiotic of B. infantis and HMO in healthy adult microbiomes without antibiotics

Prolacta Bioscience has published new research successfully using a synbiotic of human milk oligosaccharides (HMOs) with Bifidobacterium longum subsp. infantis (B. infantis) to reversibly engraft the microbe within healthy human adult microbiomes without the use of antibiotics. Within the infant microbiome, HMOs are uniquely metabolized by B. infantis to produce short-chain fatty acids such as […]

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board PAUL, MN, January 25, 2021 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc.  (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of  Infectious […]

Looking under the hood of the microbiome – functional insights through CAZyme analysis

Carbohydrate active enzymes (CAZymes) are responsible for modification of all carbohydrates, through both anabolic and catabolic pathways. Composed of five major classes and over 300 families and subfamilies, CAZymes play a role in all carbohydrate biochemistry and are vital for the well-being of many organisms. Plant pathogens like the white-rot fungus Dichomitus squalens, for example, require a repertoire of CAZymes to invade plant cells by breaking down the cell wall¹. In humans, the gut microbiome utilizes CAZymes to breakdown complex carbohydrates into smaller components aiding […]

Filling the microbiome data information gap

2020 so far has been an interesting year for me. I started the year by attending one of the biggest precision medicine conferences in the world, Precision Medicine World Conference (PMWC). The conference covered topics including immune-oncology, biomarker diagnostics, artificial intelligence, pharmacogenomics, and data science. As a product manager supporting our microbiome lab services and […]

Solving the mysteries of your pet’s gut health with Nom Nom and Diversigen

  Nom NomTM is not your average pet food company. In addition to delivering fresh, healthy meals for cats and dogs created by a team of veterinary nutritionists, they are using gut microbiome samples submitted by their customers to study the link between nutrition and pet health. Nom Nom partners with Diversigen to analyze these samples and provide […]

Best practices for improving next-generation microbiome sequencing

Dr. Daryl Gohl of the University of Minnesota Genomics Center, former CSO and founder of CoreBiome and current senior advisor to Diversigen, throughout his career has developed best practices for microbiome sequencing. In August 2019, Dr. Gohl had the opportunity to present at the National Institute of Standards and Technology (NIST) on the subject of […]

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study

ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in […]

Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services

PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve as Nom Nom’s central lab […]

Diversigen and CoreBiome consolidate as one brand

Diversigen and CoreBiome, DNA Genotek’s microbiome services sister companies, have combined their offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service. The unified Diversigen operation will continue to offer the science-driven, customized solutions for […]

OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries

OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service.   Investor Contact: Roberto Cuca Chief Financial Officer 610-882-1820 investorinfo@orasure.com Media Contact: […]